Bevacizumab/irinotecan/polyethylene glycolVarious toxicities: 6 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1721卷 / 1期

关键词：

D O I：

10.1007/s40278-018-52099-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：62 / 62

相关论文

共 50 条

[1] Bevacizumab/irinotecan/temozolomideVarious toxicities: 6 case reports
[J]. Reactions Weekly, 2017, 1637 (1) : 40 - 40
[2] Polyethylene-glycolVarious toxicities: case report
[J]. Reactions Weekly, 2019, 1759 (1) : 213 - 213
[3] Bevacizumab/dexamethasoneVarious toxicities: 6 case reports
[J]. Reactions Weekly, 2020, 1785 (1) : 112 - 112
[4] Bevacizumab/doxorubicinCardiac toxicities: 6 case reports
[J]. Reactions Weekly, 2012, 1405 (1) : 11 - 11
[5] Bevacizumab/irinotecan/temozolomideLack of efficacy: 6 case reports
[J]. Reactions Weekly, 2024, 2024 (1) : 92 - 92
[6] Bevacizumab/cisplatin/paclitaxelVarious toxicities: 6 case reports
[J]. Reactions Weekly, 2020, 1813 (1) : 62 - 62
[7] Aflibercept/bevacizumab/ranibizumabVarious toxicities: 6 case reports
[J]. Reactions Weekly, 2022, 1904 (1) : 24 - 24
[8] Bevacizumab/carboplatin/paclitaxelVarious toxicities: 6 case reports
[J]. Reactions Weekly, 2018, 1731 (1) : 62 - 62
[9] Camrelizumab/irinotecan/rivoceranibVarious toxicities and lack of efficacy: 6 case reports
[J]. Reactions Weekly, 2023, 1986 (1) : 119 - 119
[10] Irinotecan/nimotuzumabVarious toxicities: 4 case reports
[J]. Reactions Weekly, 2015, 1566 (1) : 139 - 139

← 1 2 3 4 5 →